Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome.
about
Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@en
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@nl
type
label
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@en
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@nl
prefLabel
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@en
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@nl
P2093
P2860
P1433
P1476
Evidence for elevated (LIMK2 a ...... essions in metabolic syndrome.
@en
P2093
Abdullah T Demiryürek
Belgin Alasehirli
Hasan Dagli
Mesut Ozkaya
Seniz Demiryürek
Serdar Oztuzcu
Suzan Tabur
P2860
P2888
P304
P356
10.1007/S12020-016-0910-0
P577
2016-03-08T00:00:00Z